These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8910977)

  • 21. Teratogen update: evaluation of the reproductive and developmental risks of caffeine.
    Christian MS; Brent RL
    Teratology; 2001 Jul; 64(1):51-78. PubMed ID: 11410911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NTP technical report on toxicity studies of t-butyl alcohol (CAS No. 75-65-0). Administered by inhalation to F344/N rats and B6C3F1 mice.
    Mahler J
    Toxic Rep Ser; 1997 Jul; (53):1-56, A1-D9. PubMed ID: 11803704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atenolol developmental toxicity: animal-to-human comparisons.
    Tabacova S; Kimmel CA; Wall K; Hansen D
    Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):181-92. PubMed ID: 12797460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmental toxicity of cysteamine in the rat: effects on embryo-fetal development.
    Beckman DA; Mullin JJ; Assadi FK
    Teratology; 1998; 58(3-4):96-102. PubMed ID: 9802189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NTP-CERHR expert panel report on the reproductive and developmental toxicity of methanol.
    Shelby M; Portier C; Goldman L; Moore J; Iannucci A; Jahnke G; Donkin S;
    Reprod Toxicol; 2004 May; 18(3):303-90. PubMed ID: 15082073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental toxicity of indium: embryotoxicity and teratogenicity in experimental animals.
    Nakajima M; Usami M; Nakazawa K; Arishima K; Yamamoto M
    Congenit Anom (Kyoto); 2008 Dec; 48(4):145-50. PubMed ID: 18983580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation and interpretation of maternal toxicity in Segment II studies: issues, some answers, and data needs.
    Rogers JM; Chernoff N; Keen CL; Daston GP
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):367-74. PubMed ID: 15982694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the developmental toxicity of aspirin in rabbits when administered throughout organogenesis or during sensitive windows of development.
    Cappon GD; Gupta U; Cook JC; Tassinari MS; Hurtt ME
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):38-46. PubMed ID: 12852482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental toxicity of ribavirin/IFalpha combination therapy: is the label more dangerous than the drugs?
    Polifka JE; Friedman JM
    Birth Defects Res A Clin Mol Teratol; 2003 Jan; 67(1):8-12. PubMed ID: 12749379
    [No Abstract]   [Full Text] [Related]  

  • 30. Predicting the risk of developmental toxicity from in vitro assays.
    Spielmann H
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):375-80. PubMed ID: 15979659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developmentally regulated promoters from Dictyostelium discoideum as molecular markers for testing potential teratogens.
    Tillner J; Winckler T; Dingermann T
    Pharmazie; 1996 Nov; 51(11):902-6. PubMed ID: 8985980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of adverse pregnancy outcomes and formaldehyde exposure in human and animal studies.
    Collins JJ; Ness R; Tyl RW; Krivanek N; Esmen NA; Hall TA
    Regul Toxicol Pharmacol; 2001 Aug; 34(1):17-34. PubMed ID: 11502153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Embryo/fetal development studies with hydroxypropyl methylcellulose acetate succinate (HPMCAS) in rats and rabbits.
    Cappon GD; Fleeman TL; Rocca MS; Cook JC; Hurtt ME
    Birth Defects Res B Dev Reprod Toxicol; 2003 Oct; 68(5):421-7. PubMed ID: 14745992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental toxicity of dibutyltin dichloride in cynomolgus monkeys.
    Ema M; Fukunishi K; Matsumoto M; Hirose A; Kamata E; Ihara T
    Reprod Toxicol; 2007 Jan; 23(1):12-9. PubMed ID: 17045456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics.
    Singh-Joy SD; McLain VC
    Int J Toxicol; 2008; 27 Suppl 2():93-128. PubMed ID: 18830866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural determinants of developmental toxicity in hamsters.
    Gómez J; Macina OT; Mattison DR; Zhang YP; Klopman G; Rosenkranz HS
    Teratology; 1999 Oct; 60(4):190-205. PubMed ID: 10508972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal oral (gavage) developmental toxicity study of decabromodiphenyl oxide in rats.
    Hardy ML; Schroeder R; Biesemeier J; Manor O
    Int J Toxicol; 2002; 21(2):83-91. PubMed ID: 12022634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds.
    Festag M; Viertel B; Steinberg P; Sehner C
    Toxicol In Vitro; 2007 Dec; 21(8):1631-40. PubMed ID: 17719739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An assessment of the developmental, reproductive, and neurotoxicity of endosulfan.
    Silva MH; Gammon D
    Birth Defects Res B Dev Reprod Toxicol; 2009 Feb; 86(1):1-28. PubMed ID: 19243027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re: Problems in validation of in vitro developmental toxicity assays.
    Jensen M; Newman LM; Johnson EM
    Fundam Appl Toxicol; 1989 Nov; 13(4):863-5. PubMed ID: 2636887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.